University of Rochester's Microarray Core Facility to Implement Ovation(TM) System as Standard RNA Amplification System
Facility to Utilize Ovation System Across Multiple Gene Expression Analysis Platforms
San Carlos, Calif. - NuGEN(TM) Technologies, Inc., a privately held company developing and commercializing the new standard in nucleic acid amplification and labeling systems, today announced that the University of Rochester will begin using its Ovation(TM) system as the standard RNA amplification and labeling system in its functional genomics Center. The facility will be using the Ovation System for most new studies requiring RNA amplification and labeling.
"NuGEN's Ovation technology has allowed us to re-think the way we procure and utilize samples. Since Ovation requires 1,000-fold less RNA than standard methods, we now can advise our investigators to collect less sample, which saves considerable time and expenses. Equally important is that we now have the ability to conserve samples for future uses," said Andrew Brooks, Ph.D., Director of the University Rochester's Medical Center Functional Genomics Center. "Having completed the validation of the Ribo-SPIA technology in our lab, we believe in its potential. As gene expression studies are presented to our center, we will implement Ovation RNA amplification and labeling as our new standard."
The Microarray Core Facility at the University of Rochester Medical Center is a full service microarray facility that performs high volume experiments involving RNA amplification and labeling for both academic and industrial partners on an international level. Users supply RNA from experimental tissue, and the core performs all molecular biological sample preparation including nucleic acid amplification, sample archiving, microarray hybridization and development, and gene expression validation studies, including Q-PCR.
"Gaining the UMRC's commitment to our Ribo-SPIA(TM) Technology is a critical testimonial for the power of the technology and our dedication to customer satisfaction," said Elizabeth Hutt, Vice President of Sales and Technical Service of NuGEN. "This agreement is part of an ongoing broad collaboration between NuGEN and the University of Rochester, which has validated Ovation as the method of choice across multiple tissue types and analysis platforms including spotted arrays, Affymetrix GeneChips(R), Applied Biosystems Micro Fluidic Cards and real-time Q-PCR."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
